Astrana Health Posts Record Q3 Revenue and Narrows 2026 Guidance
Astrana Health reported record third-quarter 2026 revenue of $1,023.6 million and narrowed its full-year guidance, according to TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Astrana Health has published its third-quarter 2026 results, as reported by TradingView citing the company's press release. Revenue reached a record $1,023.6 million, up 7% from a year earlier. Net income came in at $20.3 million, while adjusted EBITDA rose 13% to a record $77.2 million.
For the nine months ended September 30, 2026, net cash from operating activities was $117.1 million and free cash flow was $105.4 million. The company narrowed its full-year 2026 outlook: revenue is now expected between $3.9 billion and $4.0 billion, adjusted EBITDA between $261 million and $274 million, and free cash flow between $107.5 million and $130 million.
why it matters
Record revenue and EBITDA, combined with a narrower annual forecast, reduce uncertainty around the company's outlook, though the effect is limited to one stock. One summary of the release omitted the figures, so the numbers here come from the full press release text.
market impact
ASTH shares: record revenue and EBITDA support interest in the company's stock
tags
instruments
sources
- Astrana Health, Inc. (ASTH) Reports Q3 Results and Narrows 2026 Guidance — TradingView, 5 November 2026 at 21:05 UTC
- Astrana Health, Inc. Reports Third Quarter 2026 Results — TradingView, 5 November 2026 at 21:05 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗